Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Firm Income Reported for This Client
$60K
Not substituted for client expenses
Summary
TERUMO BLOOD AND CELL TECHNOLOGIES is an organization, based in CO. Its political footprint includes $60K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues. Political activity spans from 2023 to 2025.